{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:36:16Z","timestamp":1789626976513,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1997,1]]},"DOI":"10.1007\/bf01575117","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T12:15:18Z","timestamp":1114604118000},"page":"26-28","source":"Crossref","is-referenced-by-count":27,"title":["Oral terbinafine for treatment of pulmonaryPseudallescheria boydii infection refractory to itraconazole therapy"],"prefix":"10.1007","volume":"16","author":[{"given":"P. E.","family":"Verweij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. J. M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F. G.","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.123.3203.876","volume":"123","author":"L Ajello","year":"1956","unstructured":"Ajello L: Soil as natural reservoir for human pathogenic fungi. Science 1956, 123: 876\u2013879.","journal-title":"Science"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2307\/4589158","volume":"70","author":"WB Cooke","year":"1955","unstructured":"Cooke WB, Kabler P: Isolation of potentially pathogenic fungi from polluted water and sewage. Public Health Reports 1955, 70: 689\u2013694.","journal-title":"Public Health Reports"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/BF02276059","volume":"13","author":"CC Hung","year":"1994","unstructured":"Hung CC, Chang SC, Yang PC, Hsieh WC: Invasive pulmonary pseudallescheriasis with direct invasion of the thoracic spine in an immunocompetent patient. European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 749\u2013751.","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0025-6196(12)60571-0","volume":"60","author":"LB Travis","year":"1985","unstructured":"Travis LB, Roberts GD, Wilson WR: Clinical significance ofPseudallescheria boydii: a review of 10 years' experience. Mayo Clinic Proceedings 1985, 60: 531\u2013537.","journal-title":"Mayo Clinic Proceedings"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/0002-9343(76)90141-8","volume":"61","author":"LI Lutwick","year":"1976","unstructured":"Lutwick LI, Galgiani JN, Johnson RH, Stevens DA: Visceral fungal infections due toPetriellidium boydii: (Allescheria boydii). In vitro drug susceptibility studies. American Journal of Medicine 1976, 61: 632\u2013640.","journal-title":"American Journal of Medicine"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archderm.1996.03890280030005","volume":"132","author":"TA Ruxin","year":"1996","unstructured":"Ruxin TA, Steck WD, Helm TN, Bergfeld WF, Bolwell BJ:Pseudallescheria boydii in an immunocompromised host. Successful treatment with d\u00e9bridement and itraconazole. Archives of Dermatology 1996, 132: 382\u2013384.","journal-title":"Archives of Dermatology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF01967593","volume":"12","author":"MVM Stolk-Engelaar","year":"1993","unstructured":"Stolk-Engelaar MVM, Cox NJM: Successful treatment of pulmonary pseudallescheriasis with itraconazole. European Journal of Clinical Microbiology & Infectious Diseases 1993, 12: 142.","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/clind\/16.6.803","volume":"16","author":"SL Goldberg","year":"1993","unstructured":"Goldberg SL, Geha DJ, Marshall WF, Inwards DJ, Hoagland HC: Successful treatment of simultaneous pulmonaryPseudallescheria boydii andAspergillus fumigatus infection with oral itraconazole. Clinical Infectious Diseases 1993, 16: 803\u2013805.","journal-title":"Clinical Infectious Diseases"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1128\/AAC.31.9.1365","volume":"31","author":"G Petranyi","year":"1987","unstructured":"Petranyi G, Meingassner JG, Mieth H: Antifungal activity of the allylamine derivate terbinafine in vitro. Antimicrobial Agents and Chemotherapy 1987, 31: 1365\u20131368.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/00362178585380201","volume":"23","author":"S Shadomy","year":"1985","unstructured":"Shadomy S, Espinell-Ingroff A, Gebhart RJ: In vitro studies with SF 86-327, a new orally active allylamine derivate. Sabouraudia 1985, 23: 125\u2013132.","journal-title":"Sabouraudia"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1378\/chest.86.2.219","volume":"86","author":"JN Galgiani","year":"1984","unstructured":"Galgiani JN, Stevens DA, Graybill JR, Stevens DL, Tillinghast AJ, Levine HB:Pseudallescheria boydii infections treated with ketoconazole. Chest 1984, 86: 219\u2013224.","journal-title":"Chest"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1128\/AAC.39.6.1361","volume":"39","author":"TJ Walsh","year":"1995","unstructured":"Walsh TJ, Peter J, McGough DA, Fothergill AW, Rinaldi MG, Pizzo PA: Activities of amphotericin B and antifungal azoles alone and in combination againstPseudallescheria boydii. Antimicrobial Agents and Chemotherapy 1995, 39: 1361\u20131364.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Supplement 39","key":"CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2133.1992.tb00013.x","volume":"126","author":"VV Villars","year":"1992","unstructured":"Villars VV, Jones TC: Special features of the clinical use of oral terbinafine in the treatment of fungal diseases. British Journal of Dermatology 1992, 126, Supplement 39: 61\u201369.","journal-title":"British Journal of Dermatology"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01575117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01575117\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01575117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T10:59:30Z","timestamp":1556881170000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01575117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["BF01575117"],"URL":"https:\/\/doi.org\/10.1007\/bf01575117","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}